RxDoctor Payments Data

Zubin Irani, MD

Vascular & Interventional Radiology · Newton, MANPI 1154339612

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $28,475 of the $29,994 with a category attached, or 94.9%. 4 manufacturers reported payments, led by Penumbra, Inc. at 51.5% of the total. Reporting peaked in 2019 at $10,101 and has fallen 61.0% since, to $3,938 in 2025.

$29,994in general payments, 2019–2025

Across 34 payments — averaging $882.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$15K
  • Medtronic$14K
  • Boston Scientific$139
  • Si-bone, Inc.$60
$5,000in research payments, 2019–2025

Across 1 payment — averaging $5000.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Bard Peripheral Vascular, Inc.$5K

What the payments were for

  • Speaking & faculty fees$28,47595%
  • Food & beverage$1,5195%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Penumbra, Inc.15$15,457
Medtronic(2 entities)17$14,337
Boston Scientific1$139
Si-bone, Inc.1$60

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$29,994 in reported general payments places this provider in the 85th percentile of 89 vascular & interventional radiology providers in Massachusetts.

See all vascular & interventional radiology providers in Massachusetts

Medicare billing

Part B allowed, 2024
$251,825
Medicare patients
295
Services billed
611

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular & interventional radiology in Newton

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →